Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

NCT06194929 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Melanoma
Brain Metastases

Interventions

DRUG: Defactinib
DRUG: Avutometinib
DRUG: Encorafenib

Sponsor

University of Utah

Collaborators

[object Object]